Information  X 
Enter a valid email address

Smith & Nephew PLC Ord USD0.20 (SN.)

Related News

30-Apr-2015 07:50 AM

Smith & Nephew says Q1 revenue up 3%

Smith & Nephew has booked Q1 revenue of $1,104 million, up 3% on an underlying basis. Reported growth of 3% includes effects of -8% currency headwind offset by 8% benefit from acquisitions. The company's full-year outlook remains unchanged, it said.
15-Apr-2015 02:27 PM

Smith & Nephew schedules Q1 report

Smith & Nephew, the global medical technology business, will announce its trading report for the first quarter on 30 April. At 2:27pm: (LON:SN.) Smith Nephew PLC share price was -4.5p at 1175.5p Story provided by StockMarketWire.com...
03-Mar-2015 02:06 PM

Smith & Nephew acquires Colombian distributor ECC

Smith & Nephew, the global medical technology business, has acquired EuroCiencia Colombia. ECC has been Smith & Nephew's sole distributor for orthopaedic reconstruction, trauma and sports medicine products in Colombia since 2006. Chief executive O
05-Feb-2015 07:22 AM

SN. profit slips

Smith & Nephew's FY pretax profit came in at $714m, from $802m a year earlier. Revenue was $4.6bn, from $4.4bn. It proposed a final dividend of 18.6 cents, taking the total up 8% to 29.6 cents. CEO Olivier Bohuon said the 2014 performance reflects t
13-Nov-2014 11:24 AM

Chief executive of Reed Elsevier joins Board of Smith & Nephew

Smith & Nephew, the global medical technology business, has announced that Erik Engstrom, who has been chief executive of Reed Elsevier since 2009, is to join its Board. He will become a non-executive director at the start of next year. At 11:24am
30-Oct-2014 12:27 PM

New director at Smith & Nephew

Smith & Nephew, the global medical technology business, has announced that Vinita Bali is to join its Board as a non-executive director. on 1 December 2014. Ms Bali was most recently managing director and chief executive officer of Britannia Industries,
13-Oct-2014 03:57 PM

Smith & Nephew schedules Q3 results

Smith & Nephew, the global medical technology business, will announce its third quarter results to 27 September on 30 October. At 3:57pm: (LON:SN.) Smith Nephew PLC share price was -16.5p at 974.5p Story provided by StockMarketWire.com...
01-Aug-2014 08:29 AM

Smith & Nephew H1 pretax profit marginally lower

Smith & Nephew booked an H1 pretax profit of $349m, from $392m. Revenue totalled $2,220m, from $2,149m. In the second quarter, pretax profit was $188m, from $128m. CEO Olivier Bohuon said Sith & Nephew had delivered a good increase in revenues and tradin
11-Jul-2014 01:37 PM

Smith & Nephew ends 77-year link with external auditor

Smith & Nephew is set to change its external auditor for the first time since the company listed in 1937. Shareholders will be asked to approve KPMG as auditor for the year to 31 December 2015 - ending the company's 77-year link with Ernst & Young.
10-Jul-2014 01:01 PM

Smith & Nephew schedules interims

Smith & Nephew, the global medical technology business, will announce its results for the second quarter and half year ended 28 June on 1 August. At 1:01pm: (LON:SN.) Smith Nephew PLC share price was -5.5p at 1017.5p Story provided by StockMarketWi
29-May-2014 03:25 PM

Smith & Nephew completes ArthroCare acquisition

Smith & Nephew has completed the acquisition of ArthroCare Corporation, an innovative medical device company with a highly complementary sports medicine portfolio. The purchase price was $48.25 per share paid in cash, translating into an enterprise valu
28-May-2014 02:48 PM

Stryker does not intend to make offer for Smith & Nephew

Stryker Corporation has confirmed it does not intend to make an offer for Smith & Nephew. Stryker said it noted speculation regarding a potential transaction and recent movement in the share price of Smith & Nephew. Stryker said that at the request
01-May-2014 08:28 AM

Smith & Nephew Q1 underlying revenue up 1%

Smith & Nephew said its Q1 underlying revenue was up 1% to $1073m, from a reported $1075m. Trading profit was $229m, down 5% in underlying terms from $241m. There was a -1% currency headwind and a net zero effect from acquisitions and disposals. CEO Ol
11-Apr-2014 11:33 AM

Smith & Nephew gives notice of Q1 update

Smith & Nephew (LON:SN.), the global medical technology business, will announce its results for the first quarter ended 29 March 2014 on Thursday 1 May 2014 at 7.00am BST/2.00am EST. At 11:33am: (LON:SN.) Smith Nephew PLC share price was -17.75p at 883
06-Feb-2014 07:33 AM

Smith & Nephew FY pretax profit falls c.20%

Smith & Nephew's FY pretax profit plunged some 20% to $802m, from $1.1bn. Revenue was $4.4bn, from £4.1bn. It proposed a final dividend of $0.17 per share. CEO Olivier Bohuon said S&N finished the year strongly. Its Orthopaedic Reconstruction bus
03-Feb-2014 07:48 AM

Smith & Nephew acquires ArthroCare for c. $1.7bn

Smith & Nephew, the global medical technology business, has agreed to acquire medical device company ArthroCare Corp. for $48.25/share in cash, a total consideration of about $1.7bn and an enterprise value of $1.5bn. Story provided by StockMarketWire.
17-Jan-2014 03:13 PM

Smith & Nephew schedules Q4 results

Smith & Nephew, the global medical technology business, will announce its results for the fourth quarter to the end of December on 6 February. At 3:13pm: (LON:SN.) Smith & Nephew PLC share price was +4.75p at 878.75p Story provided by StockMarketWir
12-Dec-2013 01:56 PM

Broker News & Views

Credit Suisse retains outperform on Diageo, target cut from 2,350p to 2,200p. Numis keeps add on Smith & Nephew, target up from 870p to 960p. Goldman Sachs reiterates conviction buy on Prudential, target increased from 1,480p to 1,500p. Credit Suisse re
04-Dec-2013 01:54 PM

Smith & Nephew appoints chairman elect

Smith & Nephew has appointed Roberto Quarta as a non-executive director and chairman elect with effect from today (4 December). At 1:54pm: (LON:SN.) Smith & Nephew PLC share price was -0.5p at 828p Story provided by StockMarketWire.com...
31-Oct-2013 11:24 AM

Smith & Nephew 9-month profit slips

Smith & Nephew booked a nine-month pretax profit of $570m, down from $879m a year earlier. Revenue was $3.2b, from $3.1b. "Smith & Nephew had a strong third quarter, delivering 5% growth in revenue and 10% growth in trading profit on an underlying b
31-Oct-2013 11:21 AM

Smith & Nephew names Quarta as chairman-elect

Smith & Nephew has appointed Roberto Quarta as Non-Executive Director and Chairman Elect. He will join the Board on 4 December 2013. Subject to his re-election, he will be appointed Chairman to succeed Sir John Buchanan. At 11:21am: (LON:SN.) Smith & N
13-Aug-2013 02:40 PM

Broker News & Views

Citigroup cuts Smith & Nephew to neutral from buy, target up from 797p to 830p. Deutsche Bank retains hold on TUI Travel, target up from 335p to 355p. Investec cuts Cobham to reduce from hold, target raised from 275p to 290p. Merrill Lynch retains buy o
02-Aug-2013 02:09 PM

Broker News & Views

Berenberg lifts Weir Group to buy from hold, target up from 2,515p to 2,545p. Jefferies Int'l reiterates buy on Smith & Nephew, target up from 850p to 890p. Investec cuts Aggreko to hold from add, target cut from 1900p to 1700p. Deutsche Bank cuts
01-Aug-2013 07:19 AM

Smith & Nephew reports 3% underlying growth Q2

Prosthetics maker Smith & Nephew said revenue was $1.074bn in the second quarter to end-June, up 3% on an underlying basis or 4% reported year-on-year. There was a 1% foreign exchange headwind in the quarter. The one additional sales day year-on-year in
24-Jul-2013 02:03 PM

Broker News & Views

Morgan Stanley cuts Standard Chartered to equal-weight from overweight, target cut from 1,830p to 1,627p. Investec starts sell on Kazakhmys, target 190p. HSBC lifts Mitchells and Butlers to overweight from neutral, target raised from 410p to 500p. HSBC
 
Headlines
Top categories
Company finder
Forthcoming announcements